Patents by Inventor Scott Noggle

Scott Noggle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160222355
    Abstract: The present invention provides systems and methods for obtaining, generating, culturing, and handling cells, such as stem cells (including induced pluripotent stem cells or iPSCs), differentiated cells, and genetically engineered cells, as well as cells and cell panels produced using such systems and methods, and uses of such cells and cell panels.
    Type: Application
    Filed: December 24, 2015
    Publication date: August 4, 2016
    Inventors: Scott Noggle, Daniel John Paul
  • Publication number: 20160130561
    Abstract: In some embodiments the present invention provides cells, such as pluripotent stem cells and differentiated cells, derived from tissue samples that have been frozen without a cryoprotective agent, and also cell panels comprising such cells, model systems comprising such cells, and methods for making and using such cells, cell panels, and model systems.
    Type: Application
    Filed: June 13, 2014
    Publication date: May 12, 2016
    Inventors: Andrew Sproul, John Crary, Lauren Ab Vensand, Carmen Dusenberry, Scott Noggle, Michael Shelanski
  • Publication number: 20150166964
    Abstract: The present invention provides various improved systems and methods for obtaining, generating, culturing, and handling cells, such as stem cells (including induced pluripotent stem cells or iPSCs) and differentiated cells, as well as cells and cell panels produced using such systems and methods, and uses of such cells and cell panels.
    Type: Application
    Filed: June 27, 2014
    Publication date: June 18, 2015
    Inventors: SCOTT NOGGLE, KEVIN EGGAN, STEPHEN CHANG, SUSAN SOLOMON
  • Patent number: 8748178
    Abstract: Methods are provided for producing a human embryo capable of developing to the blastocyst stage. The method includes transferring a human somatic cell genome into a mature human oocyte by nuclear transfer and activating the oocyte, without removing the oocyte genome. Pluripotent human embryonic stem cells, and methods of obtaining these, are also provided.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: June 10, 2014
    Assignee: The New York Stem Cell Foundation
    Inventors: Dietrich M. Egli, Scott A. Noggle, Kevin C. Eggan
  • Publication number: 20120129260
    Abstract: Methods are provided for producing a human embryo capable of developing to the blastocyst stage. The method includes transferring a human somatic cell genome into a mature human oocyte by nuclear transfer and activating the oocyte, without removing the oocyte genome. Pluripotent human embryonic stem cells, and methods of obtaining these, are also provided.
    Type: Application
    Filed: November 22, 2011
    Publication date: May 24, 2012
    Applicant: THE NEW YORK STEM CELL FOUNDATION
    Inventors: Dietrich M. EGLI, Scott A. NOGGLE, Kevin C. EGGAN
  • Publication number: 20060211111
    Abstract: The present invention provides compositions and methods for mammalian neural cell production, their stabilization and their proliferation. More particularly, the present invention provides cellular differentiation methods employing culturing the cells on a cell line or in cell culture and further contacting the cells with MEDII conditioned medium for the generation of stable mammalian neural cells from pluripotent mammalian stem cells. The invention further provides methods for the stabilization of a neural cell in culture comprising contacting the neural cell with MEDII conditioned medium. Preferably, the stabilized neural cell is a neural progenitor cell.
    Type: Application
    Filed: December 18, 2003
    Publication date: September 21, 2006
    Inventors: Maisam Mitalipova, Ian Lyons, Brian Condie, Allan Robins, Scott Noggle
  • Publication number: 20060194315
    Abstract: The current invention relates to the control and/or manipulation of the gamma-secretase signaling pathway in pluripotent cells to stabilize the cells in a pluripotent state and/or to control the differentiation of the pluripotent cells towards a differentiated state. The invention further includes feeder layers that contain or express ligands or other compounds that inhibit gamma-secretase or Notch signaling to enhance the maintenance of pluripotent cells in a pluripotent state. The invention also includes cell culture compositions that comprise pluripotent cells and inhibitors of gamma-secretase, or activators or inhibitors of Notch signaling.
    Type: Application
    Filed: March 31, 2004
    Publication date: August 31, 2006
    Inventors: Brian Condie, Allan Robins, Scott Noggle